Omega Diagnostics Group PLC Allersys® CE-Mark (9977Z)

TIDMODX

RNS Number : 9977Z

Omega Diagnostics Group PLC

21 December 2017

Omega Diagnostics Group PLC

("Omega" or the "Company")

Allersys(R) CE-Mark

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked an additional eight allergens to extend its menu to 49 allergens.

Omega's aim is to enhance the product offering on a continuous basis. The investment on developing the Allersys(R) product range is being supported by the research and development grant of up to GBP1.8 million, which the Company secured from Scottish Enterprise in August 2016. The Company's pipeline includes a further nine allergens which it aims to CE-Mark over the next few months.

Colin King, Chief Executive Officer of Omega, commented: "We are pleased to extend our Allersys(R) menu and we remain on track to add further allergen tests to the menu in line with our development timelines. As noted in our interim results announcement last week, we remain positive that we will conclude commercialisation discussions with Immunodiagnostic Systems in the near future."

Contacts:

 
 Omega Diagnostics Group                               Tel: [phone] 
  PLC 
 Colin King, Chief Executive                     www.omegadiagnostics.com 
 Kieron Harbinson, Group 
  Finance Director 
 Jag Grewal, Group Sales 
  and Marketing Director 
 
 finnCap Ltd                                           Tel: [phone] 
 Geoff Nash/James Thompson 
  (Corporate Finance) 
 Mia Gardner (Corporate 
  Broking) 
 
 Walbrook PR Limited           Tel: [phone] or [e-mail] 
 Paul McManus                                          Mob: [phone] 
 Lianne Cawthorne                                      Mob: [phone] 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCDMMZZNGRGNZM

(END) Dow Jones Newswires

December 21, 2017 02:00 ET (07:00 GMT)